Skip to content

Medtronic MDT Net Change in Cash

Net Change in Cash at other companies

Abbott logo
AbbottABT
-$1.72B-58.6%
TFX
TeleflexTFX
-$84.85M-734%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Stryker logo
StrykerSYK
-$1.13B+14.9%
Artivion logo
ArtivionAORT
-$9.14M+42.0%
CONMED logo
CONMEDCNMD
-$5.79M-152%

Other financials

Income statement

See full
Revenue$9.8B+9.9%
Gross profit$6.4B+10.9%
Operating income$1.9B+30.4%
Net income$1.2B+17.8%
EPS (diluted)$0.97+18.3%

Balance sheet

See full
Cash & equivalents$1.9B-12.1%
Total debt$29.2B-1.6%
Total equity$49.5B+3.0%
Total assets$93.0B+1.5%

Cash flow

See full
Operating cash flow$2.6B+1.8%
CapEx$488.0M+6.3%
Free cash flow$2.1B+0.8%

Valuation

See full
Market cap$100.14B-9.3%
Enterprise value$127.4B-7.6%
P/E20.9×-2.8×
P/S2.8×-0.5×

Profitability

See full
Gross margin65%-0.3pp
Operating margin17.8%0.0pp
Net margin13.2%-0.7pp
FCF margin14.9%-0.5pp

Returns & leverage

See full
Return on equity9.8%+0.4pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Medtronic’s 10-Q, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medtronic's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medtronic's net change in cash?
Medtronic (MDT) reported net change in cash of -$136M in Q4 2025.
How has Medtronic's net change in cash changed year-over-year?
Medtronic's net change in cash increased by 11.7% year-over-year, from -$154M to -$136M.
What is the long-term trend for Medtronic's net change in cash?
Over 3 years (2022 to 2025), Medtronic's net change in cash has grown at a 97.6% compound annual growth rate (CAGR), from $121M to $934M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.